SCHOLAR ROCK RESUBMITS APITEGROMAB MARKETING AUTHORISATION APPLICATION (MAA) TO EUROPEAN MEDICINES AGENCY (EMA) FOR TREATMENT OF CHILDREN AND ADULTS WITH SPINAL MUSCULAR ATROPHY (SMA)

Reuters · 3d ago

Please log in to view news